Status:
NOT_YET_RECRUITING
Feasibility and Acceptability of the Remote Oncology Symptom Assessment Application
Lead Sponsor:
University of Pittsburgh
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Cancer
Solid Tumor Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The goal of this study is to determine whether a mobile application that combines real-time sensor data and patient-reported symptoms to trigger care-team contact recommendations is feasible and benef...
Detailed Description
Participants (n=50) will be recruited from UPMC Hillman clinics. If eligible patients consent to participate, they will complete online baseline, midpoint, and end of study questionnaires. Participan...
Eligibility Criteria
Inclusion
- Receiving chemotherapy at the UPMC Hillman Cancer Center for any solid tumor cancer at any stage with at least two cycles remaining;
- age 18 years or older;
- ability to read and write in English;
- sufficient performance status to participate in research (e.g., Karnofsky performance status of 60-100%); and
- owns and uses an Android smartphone or an iPhone capable of running the study apps.
Exclusion
- under 18 years old; and
- unable to read and write in English
Key Trial Info
Start Date :
January 19 2026
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2026
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT07218874
Start Date
January 19 2026
End Date
December 31 2026
Last Update
January 7 2026
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UPMC Hillman Cancer Center
Pittsburgh, Pennsylvania, United States, 15232